Insiders · Profile

Rosett Max

Chief Financial Officer at Immunome. Filing since 19 Sep 2024. CIK 0001994071

Company

Date

Role

Action

Amount

Of holding

15 Jun 2026

Chief Financial Officer

Sold on a plan

60,000

$1.09M

52.6%

2 Apr 2026

Chief Financial Officer

Sold on a plan

65,000

$1.42M

54.6%

19 Sep 2024

Chief Financial Officer

Sold at will

14,380

$230.22K

23.2%

3 decisions on file.